[1] Wang C, Peng J, Lu S et al. Summary of the various treatments for osteonecrosis of the femoral head by mechanism: a review. Exp Ther Med, 2014;8(3):700-706.
[2] TSakano-Murakam IR, Tokunaga K, Kondo N, et al. Glucocorticoid inhibits bone regeneration after osteonecrosis of the femoral head in aged female rats. Tohoku J Exp Med. 2009;217(1):51-58.
[3] Kuribayashi M, Fujioka M, Takahashi KA, et al. Combination analysis of three polymorphisms for predicting the risk for steroid-induced osteonecrosis of the femoral head. J Orthop Sci. 2008;13(4):297-303.
[4] Chernetsky SG, Mont MA, La Porte DM, et al. Pathologic features insteroid and nonsteroid associated osteonecrosis. Clin Orthop. 1999;368:149-161.
[5] Jones LC, Hangerford DS. The pathogenesis of osteonecrosis. Instr Course Lect. 2007;56(1):179-196.
[6] Guo KJ, Zhao FC, Guo Y et al. The influence of age, gender and treatment with steroids on the incidence of osteonecrosis of the femoral head during the management of severe acute respiratory syndrome: a retrospective study. Bone Joint J. 2014;96-B(2):259-262.
[7] Varoga D, Drescher W, Pufe M, et al. Differential expression of vascular endothelial growth factor in glucocorticoid-related osteonecrosis of the femoral head. Clin Orthop Relat Res. 2009;467(12):3273-3282.
[8] Nishida K, Yamamoto T, Motomura G, et al. Pitavastatin may reduce risk of steroid-induced osteonecrosis in rabbits: a preliminary histological study. Clin Orthop Relat Res. 2008; 466(5):1054-1058.
[9] Zheng CY, Li XD, Du SX. The role of connexin43 in bone development and shaping. Int J Orthop. 2009;30(2):134-136.
[10] 李瑞琦,张国平,李宜炯.激素性股骨头坏死模型:不同构建技术分析[J].中国组织工程研究,2013,17(37):6676-6681.
[11] Shi B, Li G, Wang P. Effect of antler extract on corticosteroid-induced avascular necrosis of the femoral head in rats. J Ethnopharmacol. 2010;127(1):124-129.
[12] 赵金东,吕松岑,薛震等.激素性股骨头坏死动物模型的建立与评价[J].中国骨肿瘤骨病,2007;6(4):220-224.
[13] Orimo H. The mechanism of mineralization and the role of alkaline phosphatase in health and disease. J Nippon Med Sch. 2010;77(1):4-12.
[14] 贾岩波,刘万林,任逸众.激素性股骨头坏死发病机制中细胞凋亡的研究进展[J].中国组织工程研究,2012,16(13):2444-2450.
[15] O'Brien CA, Jia D, Plotkin LI, et al. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology. 2004; 145(4):1835-1841.
[16] Yun SI, Yoon HY, Jeong SY, et al. Glucocorticoid induces apoptosis of osteoblast cells through the activation of glycogen synthase kinase 3beta. J Bone Miner Metab. 2009; 27(2):140-148.
[17] Hofbauer LC, Gorl F, Riggs BL, et al. Stimulation of osteop rotegerin ligand and inhibition of osteoprotegerin production byglucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocoticoid-induced osteoporosis. Endocrinology. 1999;140(10):4382-4389.
[18] Moraes LA, Paul-Clark MJ, Rickman A, et al. Ligand-specific glucocorticoid receptor activation in human platelets. Blood. 2005;106(13):4167-4175.
[19] 暴淑英,赵国庆,毕黎琦.激素性股骨头坏死早期细胞凋亡相关基因表达及阿轮磷酸钠的干预[J].中国组织工程研究与临床康复, 2008,12(46):9095-9099.
[20] Kogianni G, Mann V, Ebetino F et al. Fas/CD95 is associated with glucocorticoid-induced osteocyte apoptosis. Life Sciences. 2004;75(24):2879-2895.
[21] Plotkin LI. Connexin 43 hemichannels and intracellular signaling in bone cells. Front Physiol. 2014;5:131.
[22] Buo AM, Stains JP. Gap junctional regulation of signal transduction in bone cells. FEBS Lett. 2014;588(8): 1315-1321.
[23] Chung DJ, Castro CH, Watkins M, et al. Low peak bone mass and attenuated anabolic response to parathyroid hormone in mice with an osteoblast-specific deletion of connexin 43. J Cell Sci. 2006;119(20):4187-4198.
[24] Bivi N, Condon KW, Allen MR, et al. Cell autonomous requirement of connexin 43 for osteocyte survival: consequences for endocortical resorption and periosteal bone formation. J Bone Miner Res. 2012;27(2):374-389.
[25] Siller-Jackson AJ, Burra S, Gu S, et al. Adaptation of connexin 43-hemichannel prostaglandin release to mechanical loading. J Biol Chem. 2008;283(39):26374-26382.
[26] Niger C, Buo AM, Hebert C, et al. ERK acts in parallel to PKC to mediate the connexin43-dependent potentiation of Runx2 activity by FGF2 in MC3T3 osteoblasts. Am J Physiol Cell Physiol. 2012;302(7):C1035-C1044.
[27] Niger C, Luciotti MA, Buo AM. The regulation of Runx2 by FGF2 and connexin43 requires the inositol polyphosphate/protein kinase Cδ cascade. J Bone Miner Res. 2013;28(6):1468-1477.
[28] Bivi N, Pacheco-Costa R, Brun LR, et al. Absence of Cx43 selectively from osteocytes enhances responsiveness to mechanical force in mice. J Orthop Res. 2013;31(7):1075-1081.
[29] Mureli S, Gans CP, Bare DJ, et al. Mesenchymal stem cells improve cardiac conduction by upregulation of connexin 43 through paracrine signaling. Am J Physiol Heart Circ Physiol. 2013;304(4):600-609.
[30] Kitase Y, Barragan L, Qing H, et al. Mechanical induction of PGE2 in osteocytes blocks glucocorticoid-induced apoptosis through both the beta-catenin and PKA pathways. J Bone Miner Res. 2010;25(12):2657-2668.
[31] Schrobback K, Klein TJ, Woodfield TB. The importance of connexin hemichannels during chondroprogenitor cell differentiation in hydrogel versus microtissue culture models. Tissue Eng Part A. 2015.
[32] Plotkin LI, Speacht TL, Donahue HJ. Cx43 and Mechanotransduction in Bone. Curr Osteoporos Rep. 2015.
[33] Piryaei A, Soleimani M, Heidari MH, et al. Ultrastructural maturation of human bone marrow mesenchymal stem cells-derived cardiomyocytes under alternative induction of 5-azacytidine. Cell Biol Int. 2015. doi: 10.1002/cbin.10421.
[34] Reikvam H, Ryningen A, Sæterdal LR, et al. Connexin expression in human acute myeloid leukemia cells: Identification of patient subsets based on protein and global gene expression profiles. Int J Mol Med. 2015;35(3):645-652.
[35] Zhang J, Wang LL, Du W, et al. Hepatocyte growth factor modification enhances the anti-arrhythmic properties of human bone marrow-derived mesenchymal stem cells. PLoS One. 2014;9(10):e111246.
[36] Xu H, Gu S, Riquelme MA, et al. Connexin 43 Channels are Essential for Normal Bone Structure and Osteocyte Viability. J Bone Miner Res. 2015;30(3):550-562.
[37] Kuang W, Tang M, He X, et al. Differentiation of rat bone marrow-derived mesenchymal stem cells into cardiomyocyte-like cells induced by cyclic stretching strain. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2014;31(3): 596-600.
[38] Rahimi M, Zarnani AH, Mohseni-Kouchesfehani H, et al. Comparative evaluation of cardiac markers in differentiated cells from menstrual blood and bone marrow-derived stem cells in vitro.Mol Biotechnol. 2014;56(12):1151-1162.
[39] Geng X, Liu S, Chen Y. Involvement of ERK5 and JNK in the BMP9-induced differentiation of C3H10T1/2 cells into cardiomyocyte-like cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014;30(8):829-832, 840.
[40] Gao Q, Guo M, Jiang X, et al. A cocktail method for promoting cardiomyocyte differentiation from bone marrow-derived mesenchymal stem cells. Stem Cells Int. 2014;2014:162024.
[41] Pidoux G, Gerbaud P, Dompierre J, et al. A PKA-ezrin-Cx43 signaling complex controls gap junction communication and thereby trophoblast cell fusion. J Cell Sci. 2014;127(Pt 19): 4172-4185.
[42] Nogueira-Pedro A, Dias CC, Regina H, et al. Nitric oxide-induced murine hematopoietic stem cell fate involves multiple signaling proteins, gene expression, and redox modulation. Stem Cells. 2014;32(11):2949-2960.
[43] Sadr-Eshkevari P, Ashnagar S, Rashad A, et al. Bisphosphonates and connexin 43: a critical review of evidence. Cell Commun Adhes. 2014;21(5):241-247.
[44] Hobolt-Pedersen AS, Delaissé JM, Søe K. Osteoclast fusion is based on heterogeneity between fusion partners. Calcif Tissue Int. 2014;95(1):73-82.
[45] Damaraju S, Matyas JR, Rancourt DE, et al. The effect of mechanical stimulation on mineralization in differentiating osteoblasts in collagen-I scaffolds. Tissue Eng Part A. 2014; 20(23-24):3142-3153.
[46] Zappitelli T, Aubin JE. The "connexin" between bone cells and skeletal functions. J Cell Biochem. 2014;115(10):1646-1658.
[47] Plotkin LI. Connexin 43 hemichannels and intracellular signaling in bone cells. Front Physiol. 2014;5:131.
[48] Lloyd SA, Loiselle AE, Zhang Y, et al. Evidence for the role of connexin 43-mediated intercellular communication in the process of intracortical bone resorption via osteocytic osteolysis. BMC Musculoskelet Disord. 2014;15:122.
[49] Komori T. Mouse models for the evaluation of osteocyte functions. J Bone Metab. 2014;21(1):55-60.
[50] Li N, Pasha Z, Ashraf M. Reversal of ischemic cardiomyopathy with Sca-1+ stem cells modified with multiple growth factors. PLoS One. 2014;9(4):e93645. |